Cardiology (all articles) | Page 37 of 178 | Links Medicus Content Curation & Alerts in Medicine

Cohort Study | Albuminuria as a marker of systemic congestion in patients with heart failure.

7 Oct, 2022 | 14:19h | UTC

Albuminuria as a marker of systemic congestion in patients with heart failure – European Heart Journal

Cohort Study | Differential patterns and outcomes of 20.6 million cardiovascular ED encounters for men and women in the US.

7 Oct, 2022 | 14:18h | UTC

Differential Patterns and Outcomes of 20.6 Million Cardiovascular Emergency Department Encounters for Men and Women in the United States – Journal of the American Heart Association

News Release: Many heart-related emergencies are due to uncontrolled blood pressure – American Heart Association

Commentary: High BP Tied to One in Eight Emergency Visits for Cardiovascular Issues – HealthDay

Commentary on Twitter

In an analysis of >20 million cardiovascular ED visits from 2016-2018, women presenting with ICH or aortic aneurysm/dissection had higher death risk than men, but lower risk when presenting with AF, acute MI, or cardiac arrest #AHAJournals https://t.co/MUmtG725FS

— JAHA (@JAHA_AHA) September 15, 2022

Consensus Paper | Use of coronary CT angiography for patients with acute chest pain in the emergency department.

7 Oct, 2022 | 14:16h | UTC

2022 Use of Coronary Computed Tomographic Angiography for Patients Presenting with Acute Chest Pain to the Emergency Department: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the American College of Radiology (ACR) and North American Society for Cardiovascular Imaging (NASCI) – Journal of Cardiovascular Computed Tomography

Commentary: Acute Chest Pain in the ED? SCCT Offers Guidance for Using CCTA – TCTMD

Cohort Study | Association of thoracic aortic aneurysm size with long-term patient outcomes.

6 Oct, 2022 | 13:47h | UTC

Association of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA Study – JAMA Cardiology (free for a limited period)

Commentary on Twitter

Risk of dissection is low for non-syndromic pts with ascending aortic aneurysm. Risk higher w larger size, but with a 6.0cm inflection point, early surgery for Pts <5.5 cm should be selective, as the risks from aortic surgery may outweigh the benefits. https://t.co/Mgf1TtHkzr

— JAMA Cardiology (@JAMACardio) October 5, 2022

RCT | Telmisartan did not improve walking performance in patients with lower extremity peripheral artery disease.

6 Oct, 2022 | 13:43h | UTC

Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Telmisartan and Walking Performance in Peripheral Artery Disease – JAMA (free for a limited period)

Audio interview: Treatment of Peripheral Artery Disease – JAMA

Commentary on Twitter

Study results do not support #telmisartan for improving walking performance in patients with lower extremity #PeripheralArteryDisease https://t.co/QErZh3i3rO pic.twitter.com/nhthGoIQym

— JAMA (@JAMA_current) October 5, 2022

Cohort Study | Artificial intelligence-enabled retinal vasculometry for prediction of cardiovascular diseases.

5 Oct, 2022 | 13:53h | UTC

Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke – British Journal of Ophthalmology

Editorial: The eyes as a window to the heart: looking beyond the horizon – British Journal of Ophthalmology

Commentary: AI eye checks can predict heart disease risk in less than minute, finds study – The Guardian

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.

An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.

Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.

Brief Review | How do we maximize diuresis in acute decompensated heart failure?

5 Oct, 2022 | 13:51h | UTC

How do we maximize diuresis in acute decompensated heart failure? – Cleveland Clinic Journal of Medicine

Editorial: Decongesting heart failure with diuretics: Easier to prescribe than to fully understand – Cleveland Clinical Journal of Medicine

Brief Review | Atrial fibrillation: rate control or rhythm control?

5 Oct, 2022 | 13:50h | UTC

Atrial fibrillation: Rate control or rhythm control? – Cleveland Clinic Journal of Medicine

RCT | Intrapartum extended-release nifedipine to prevent severe intrapartum hypertension in patients with severe preeclampsia.

4 Oct, 2022 | 14:37h | UTC

Trial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension Among Pregnant Individuals With Preeclampsia With Severe Features – Hypertension (link to abstract – $ for full-text)

News Release: Severe preeclampsia treated safely with nifedipine during labor and delivery – American Heart Association

M-A | Beta-blocker treatment in the critically ill.

4 Oct, 2022 | 14:30h | UTC

Beta-blocker treatment in the critically ill: a systematic review and meta-analysis – Annals of Medicine

M-A of randomized trials | Colchicine and coronary heart disease risks.

3 Oct, 2022 | 14:00h | UTC

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine

M-A: Colchicine after percutaneous coronary intervention significantly reduces the risk of major adverse cardiovascular events in patients with symptomatic coronary artery disease.

Expert Analysis | Colchicine in acute coronary syndrome: when to commence?

M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

Long-term follow-up of a RCT | P2Y12 inhibitor monotherapy vs. DAPT after percutaneous coronary intervention.

3 Oct, 2022 | 13:58h | UTC

Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Original Study: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention

Commentary on Twitter

In #RCT follow-up, P2Y12 inhibitor monotherapy after 3 months of DAPT found to be comparable with prolonged DAPT for preventing ischemic events. P2Y12 inhibitor monotherapy resulted in significantly lower rate of major bleeding for up to 3 yrs. https://t.co/pBv9X87lEg #Research pic.twitter.com/42Y28hPPT2

— JAMA Cardiology (@JAMACardio) September 30, 2022

RCT | Induced hypothermia did not improve survival or functional outcomes after in-hospital cardiac arrest.

30 Sep, 2022 | 12:43h | UTC

Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial – Circulation (free for a limited period)

Hypothermic versus Normothermic Temperature Control after Cardiac Arrest – NEJM Evidence

ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (if the link is paywalled, try this one)

Target temperature management following cardiac arrest: a systematic review and Bayesian meta-analysis – Critical Care

Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets – Intensive Care Medicine

Targeted Temperature Management for Cardiac Arrest Due to Non-shockable Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Frontiers in Medicine

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial – JAMA

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest – New England Journal of Medicine

Commentary on Twitter

New RCT of hypothermia (32-34°C) vs normothermia in IHCA 🧠❄️

👥 249 patients (25% shockable, 78% outside ICU/ED)
➡️ similar mortality at 180d (73% vs 71%)
➡️ similar favorable neuro outcome at 180d (23% vs 24%)

🔗 @CircAHA https://t.co/1Axq8a5Wrn #ResusTwitter @thiele_holger pic.twitter.com/Jh69CHuUWZ

— Tommaso Scquizzato, MD (@tscquizzato) September 29, 2022

Study | Plaque histology and myocardial disease in sudden coronary death.

30 Sep, 2022 | 12:41h | UTC

Plaque histology and myocardial disease in sudden coronary death: the Fingesture study – European Heart Journal

Cohort Study | Cardiovascular MRI phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis.

30 Sep, 2022 | 12:39h | UTC

Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: Cardiovascular magnetic resonance imaging phenotype with pathology-frequent late gadolinium enhancement associated with high-risk of ventricular arrhythmic and heart failure events – Physician’s Weekly

Commentary on Twitter

Cardiovascular magnetic resonance phenotypes could be used to optimize clinical decision-making for treatment options, such as implantable cardioverter-defibrillators, and thus improve outcomes in patients with suspected cardiac #sarcoidosis. https://t.co/6hlpPFd7cd #Research

— JAMA Cardiology (@JAMACardio) September 14, 2022

Cohort Study | Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention.

29 Sep, 2022 | 13:33h | UTC

Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention – Journal of the American College of Cardiology

RCT | Abbreviated antiplatelet therapy after coronary stenting in patients with myocardial infarction at high bleeding risk.

29 Sep, 2022 | 13:32h | UTC

Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk – Journal of the American College of Cardiology

Original publication: #ESCCongress – RCT: In patients who underwent PCI at high bleeding risk, 1 month of dual antiplatelet therapy was noninferior to the continuation of dual therapy for at least 2 additional months and resulted in a lower incidence of bleeding events.

Temporal association between invasive procedures and infective endocarditis.

29 Sep, 2022 | 13:26h | UTC

Temporal association between invasive procedures and infective endocarditis – Heart

Cohort Study | The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality.

28 Sep, 2022 | 13:49h | UTC

The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank – European Journal of Preventive Cardiology

Commentary: Expert reaction to study on coffee drinking and increased longevity – Science Media Centre

“However, with observational research like this, you can’t be sure what direction the relationship goes e.g. does coffee make you healthy or do inherently healthier people consume coffee?” (from Science Media Centre)